Our CEO Giovanni Amabile and Scientific Founder Paolo Fiorina sat down with JDRF T1D Fund Managing Director Katie Ellias to discuss our novel approach to the treatment of autoimmune disorders. The JDRF T1D Fund is one of our key investors and we are thankful for their support.

Duration 12:15

Circulating hormones control gut stem cell in diabetes
(Featuring Paolo Fiorina, Enthera’s CSO)

Duration 3:58